Molecular profiling of patients with cytogenetically normal acute myeloid leukemia and hyperleukocytosis.

Despite these unique molecular features, clinical risk factors, including high white blood count, hemoglobin level, and lactate dehydrogenase level at baseline, remained the predictors for overall survival and relapse-free survival in hyperleukocytotic CN-AML.